MSKCC in the News: June 6 – July 11

Posted on July 11, 2013 by Mark

Dr. Mark Kris was interviewed on CBS This Morning about MSKCC’s collaboration with IBM’s Watson.
MSKCC’s Dr. Arthur Brown will deliver the keynote address at the 2013 Medgate User Group Conference.
Researchers at MSKCC, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
MSKCC will purchase the former Lucent building on Red Hill Road for $14 million, according to a report in The Star-Ledger.

MSKCC in the News: May 15 – June 5

Posted on June 5, 2013 by Mark

Researchers from MSKCC reported results of the first clinical trial ever to show that a drug helped patients with advanced uveal melanoma at the American Society of Clinical Oncology Meeting in Chicago.
MSKCC’s Charles L. Sawyers, MD, was this year’s recipient of the ASCO Science of Oncology Award.
Carol Aghajanian of MSKCC was quoted in a Bloomberg article about a simple screening program for cervical cancer using vinegar and visual exams.
Jedd Wolchok of MSKCC is quoted in a Nature article about the possibility of combination approaches expanding the number of cancers that respond to immunotherapy.
Sotheby’s auctioneer and raconteur Jamie Niven was the guest of honor at a dinner hosted by the Society of Memorial Sloan-Kettering Cancer Center.

Posted on May 14, 2013 by Mark

Christopher Lima of MSKCC was selected to join the Howard Hughes Medical Institute Investigator Program.
Gopa Iyer of MSKCC was awarded the James Family Young Investigator Award for “Identifying Predictors of Response to mTOR-targeted Therapies in Bladder Cancer.”
Foundation Medicine and MSKCC announced a partnership that brings together clinical, genomic and computational expertise to advance patient care in hematologic cancers.
Scientists from The Children’s Hospital of Philadelphia and MSKCC published results in the journal Cell Stem Cell of a new model cell system that allows neuroscientists to investigate normal brain development, as well as to identify specific disruptions in biological signals that may contribute to neuropsychiatric diseases.
Nature published findings from a large-scale genomic analysis led by researchers at MSKCC and other centers within The Cancer Genome Atlas (TCGA) Research Network that may help diagnose endometrial cancer and lead to new drug development.
MSKCC’s Dr. Kenneth Offit is quoted in an NPR article about Angelina Jolie’s decision to have a preventive double mastecomy.